Naproxen Hualan Pharmaceuticals

Naproxen, the active ingredient in Naproxen Hualan Pharmaceuticals, is a nonsteroidal anti-inflammatory drug (NSAID) presented as an oral dosage form for systemic use. It is employed to relieve pain, reduce inflammation and lower fever in adult patients.

GNH USA supplies Naproxen Hualan Pharmaceuticals as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Naproxen is an NSAID that acts on inflammatory pathways to provide symptomatic relief in several conditions.

- Pain: reduces mild to moderate acute pain such as dental or musculoskeletal discomfort. - Inflammation: diminishes swelling and tissue irritation associated with inflammatory disorders. - Fever: lowers elevated body temperature in febrile states. - Arthritis: alleviates joint pain and stiffness in osteoarthritis and rheumatoid arthritis.

Naproxen may cause a variety of adverse reactions, ranging from mild to severe.

Common Side Effects: - Gastrointestinal upset: nausea, dyspepsia, or abdominal discomfort. - Headache: mild to moderate intensity. - Dizziness or vertigo. - Skin rash or pruritus. - Mild elevation of liver enzymes.

Serious or Rare Side Effects: - Gastrointestinal bleeding or perforation. - Peptic ulcer disease. - Cardiovascular events such as myocardial infarction or stroke. - Acute renal failure or worsening of chronic kidney disease. - Severe skin reactions (e.g., Stevens‑Johnson syndrome). - Hepatotoxicity with marked liver enzyme elevation.

Before initiating therapy, clinicians should evaluate patient‑specific risk factors and monitor for adverse events.

- Assess gastrointestinal risk: consider ulcer history or concurrent NSAID use. - Monitor renal function: especially in patients with dehydration or pre‑existing kidney disease. - Use the lowest effective dose: to minimize systemic exposure. - Avoid in known hypersensitivity: discontinue if allergic reactions occur. - Caution with cardiovascular disease: evaluate risk‑benefit in patients with heart disease. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Naproxen can alter the pharmacodynamics or pharmacokinetics of several medicines; careful review is required.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased bleeding risk. - Selective serotonin reuptake inhibitors (SSRIs): heightened gastrointestinal hemorrhage. - Lithium: potential for increased lithium levels and toxicity. - Methotrexate: reduced clearance leading to toxicity. - ACE inhibitors or ARBs: may impair renal function.

Moderate Interactions (Monitor Closely): - Diuretics: possible reduction in renal perfusion. - Antihypertensives: NSAID‑induced sodium retention may blunt effect. - Corticosteroids: additive risk of gastrointestinal ulceration. - Other NSAIDs: increased adverse event profile. - Alcohol: synergistic gastric irritation and bleeding risk.